VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SBC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SBCSBC Medical Group Holdings Incorporated
$3.15$324M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSBCQuarterly Financials

SBC Medical Group Holdings Incorporated (SBC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

SBC Medical Group Holdings Incorporated (SBC) quarterly income statement — complete revenue, gross profit & net income history

SBC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue43.06M39.57M43.35M43.36M47.33M44.42M53.08M53.1M54.81M62.35M47.28M41M
Revenue Growth %-9.02%-10.93%-18.33%-18.35%-13.65%-28.76%12.28%29.51%27.72%---
Cost of Goods Sold13.02M10.64M13.45M13.35M9.6M10.55M9.85M13.68M15.29M18.98M13.78M9.08M
COGS % of Revenue30.25%26.89%31.03%30.79%20.27%23.75%18.55%25.77%27.89%30.44%29.15%22.14%
Gross Profit30.04M28.93M29.9M30.01M37.73M33.87M43.24M39.42M39.52M43.37M33.5M31.92M
Gross Margin %69.75%73.11%68.97%69.21%79.73%76.25%81.45%74.23%72.11%69.56%70.85%77.86%
Gross Profit Growth %-20.4%-14.6%-30.85%-23.87%-4.52%-21.89%29.08%23.48%38.59%---
Operating Expenses12.32M16.08M14.02M15.46M13.53M29.15M29.4M12.13M15.06M19.38M13.48M16.35M
OpEx % of Revenue28.6%40.64%32.34%35.65%28.59%65.63%55.39%22.84%27.47%31.08%28.5%39.88%
Selling, General & Admin12.32M18.63M13.95M14.39M12.82M13.9M29.25M11.83M14.96M19.35M13.45M16.19M
SG&A % of Revenue28.6%47.09%32.18%33.19%27.1%31.29%55.11%22.27%27.29%31.03%28.44%39.49%
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses0-1000K70.77K1000K706.87K1000K151.61K300.89K100.06K28.26K28.52K160.2K
Operating Income17.72M12.85M15.88M14.55M24.2M4.72M13.83M27.29M24.46M23.99M20.02M15.57M
Operating Margin %41.15%32.47%36.63%33.57%51.14%10.62%26.06%51.39%44.63%38.48%42.35%37.97%
Operating Income Growth %-26.78%172.36%14.79%-46.67%-1.06%-80.33%-30.91%75.27%120.82%---
EBITDA18.39M13.52M16.6M15.19M24.83M5.65M14.85M28.12M25.48M26.55M23.31M19.17M
EBITDA Margin %42.71%34.18%38.28%35.03%52.46%12.72%27.98%52.96%46.49%42.58%49.31%46.76%
EBITDA Growth %-25.94%139.37%11.74%-45.98%-2.55%-78.72%-36.28%46.67%83.64%---
D&A (Non-Cash Add-back)670.43K673.68K714.75K636.1K628.3K931.6K1.02M830.95K1.02M2.56M3.29M3.6M
EBIT17.72M18.62M18.56M13.59M31.46M6.07M13.11M27.09M27.21M23.57M21.07M15.57M
Net Interest Income6.56K-56.09K71.75K-26.77K49.13K-12.4K2.48K4.22K14.68K-7.51K6.26K-14.9K
Interest Income121.37K0120.38K22.88K55.33K07.95K11.64K17.69K40310.23K0
Interest Expense114.81K56.09K48.63K49.65K6.21K12.4K5.47K7.42K3.01K7.91K3.98K14.9K
Other Income/Expense1.14M5.72M2.63M-1.01M7.25M1.34M-726.75K-204.13K2.74M-424.18K1.05M1.1M
Pretax Income18.86M18.57M18.51M13.54M31.45M6.06M13.11M27.09M27.2M23.57M21.07M16.67M
Pretax Margin %43.79%46.93%42.69%31.23%66.45%13.64%24.69%51.01%49.63%37.8%44.57%40.66%
Income Tax7.53M4.29M5.67M11.1M9.96M-488.55K10.27M8.53M8.45M9.34M13.01M6.81M
Effective Tax Rate %39.92%23.09%30.66%81.98%31.67%-8.06%78.38%31.49%31.07%39.62%61.76%40.88%
Net Income11.31M14.2M12.82M2.46M21.5M6.54M2.83M18.48M18.76M14.34M8.36M10.67M
Net Margin %26.26%35.89%29.58%5.67%45.43%14.72%5.34%34.81%34.22%23%17.67%26.02%
Net Income Growth %-47.41%117.16%352.7%-86.7%14.63%-54.41%-66.1%73.25%212.5%---
Net Income (Continuing)11.33M14.28M12.83M2.44M21.49M6.55M2.83M18.56M18.75M14.23M8.06M9.86M
Discontinued Operations000000000000
Minority Interest15.04M15.02M70.91K60.58K-123.83K-87K539.37K359.28K337.28K1.65M00
EPS (Diluted)0.110.140.120.020.210.060.030.200.200.150.090.02
EPS Growth %-47.62%120.13%302.68%-88.1%5.47%-58.24%-66.4%866.18%389.19%---
EPS (Basic)0.110.140.120.020.210.060.030.200.200.150.090.02
Diluted Shares Outstanding102.58M102.58M102.64M103.51M103.28M102.75M95.1M94.19M94.19M94.19M94.19M9.49M
Basic Shares Outstanding102.58M102.58M102.64M103.51M103.28M102.75M95.1M94.19M94.19M94.19M94.19M9.49M
Dividend Payout Ratio----------1197.63%-